6th January|Blogs, Investor Media, News

Duo of new SlimBiome® products to launch in India

OptiBiotix Health PLC (‘OptiBiotix’), a life sciences business developing compounds to tackle obesity, cardiovascular disease and diabetes, has announced the commercial launch of two innovative new health products containing SlimBiome® to the Indian market.

In partnership with fully integrated pharmaceutical and biotechnology businesses Anthem BioPharma Pvt Ltd (‘Anthem BioPharma’) and Zeon Life Sciences (‘Zeon’), two new products have now been made available to consumers in India. Both innovations contain patented SlimBiome®, further boosting the significant global commercial presence of the award-winning functional ingredient.

The newly-launched Metalite is a supplement to aid with effective weight management. Metalite makes use of SlimBiome’s patented combination of naturally derived ingredients to facilitate effective weight loss without relying on willpower alone.

In addition, Metalite Pro has become India’s first and only high protein meal replacement product for weight reduction, which harnesses SlimBiome to promote a feeling of fullness while supporting strong diversity of gut microbiota. Metalite Pro contains an effective blend of protein, carbohydrates and fats, as well as being fortified with vitamins and minerals.

Dr Fred Narbel, Managing Director of the prebiotics divison at OptiBiotix, commented: “We are delighted to announce our commercial partnership with Anthem BioPharma alongside Zeon. Our global presence continues to go from strength to strength and India is a perfect example of how SlimBiome meets the growing market demands. Rising urbanisation and rapidly growing consumption of processed food has led many to seek naturally derived weight management solutions.

“Metalite and Metalite Pro are great examples of health innovations that meet shifting consumer demands and break new ground in the region. It truly showcases the versatility and flexibility of SlimBiome as an ingredient, and we are confident in our ability to replicate similar partnerships in other markets and geographies.“